ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding ImageneBio, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 39 | 49 | +10 |
| Shares | 20.9M | 27.4M | +6.51M (+31.2%) |
| Value | $271.8M | $343.6M | +$71.8M (+26.4%) |
New holders (13)
Institutions that held ImageneBio, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62.9M | 5.78% |
| Qube Research & Technologies Ltd | 42,788 | $537.0K | 0.00% |
| Rhumbline Advisers | 28,102 | $352.0K | 0.00% |
| Millennium Management LLC | 17,333 | $217.0K | 0.00% |
| Susquehanna International Group, LLP | 14,567 | $183.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 13,936 | $175.0K | 0.00% |
| Goldman Sachs Group Inc | 12,864 | $161.0K | 0.00% |
| MetLife Investment Management | 11,742 | $147.2K | 0.00% |
| ProShare Advisors LLC | 11,111 | $138.0K | 0.00% |
| SG Americas Securities, LLC | 9,353 | $117.0K | 0.00% |
| Metropolitan Life Insurance Co | 8,698 | $109.1K | 0.00% |
| Baystate Wealth Management LLC | 2,999 | $38.0K | 0.00% |
| Daiwa Securities Group Inc. | 105 | $1.00K | 0.00% |
Sold out (3)
Institutions that held ImageneBio, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Octagon Capital Advisors LP | 275,000 | $3.47M |
| Credit Suisse AG | 199,781 | $2.52M |
| UBS Group AG | 85 | $1.00K |